Antileucotrienos. Su uso en pediatría

Allergologia et Immunopathologia

Volumn 28, Issue 3, 2000, Pages 136-143

  Garde, J Ma G ^a   Haro, E ^a   Sanchez Lucas C ^a   Garde Noguera, J ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

Author keywords

Asthma; Leukotriene antagonists; Montelukast

Indexed keywords

ACETIC ACID DERIVATIVE; ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; BECLOMETASONE; CORTICOSTEROID; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; NEDOCROMIL; NONSTEROID ANTIINFLAMMATORY AGENT; QUINOLINE DERIVATIVE; PEPTIDOLEUKOTRIENE;

ALGORITHM; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; HUMAN; METABOLISM; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ANTIINFLAMMATORY ACTIVITY; CONFERENCE PAPER; MEDICAL LITERATURE; PRACTICE GUIDELINE;

ACETATES; ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ALGORITHMS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; BECLOMETHASONE; CHILD; CLINICAL TRIALS; DOUBLE-BLIND METHOD; HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENES; NEDOCROMIL; QUINOLINES; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0034180563     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Knorr B, Matz J, Bernstein JA, Nguyen H, Seiidenberg BC, Reiss TF et al. Montelukast for chronic asthma in 6-60 12-year old children. A randomized, double-blind trial. JAMA 1998;729:1181-6.
2. Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB et al. Montelukast, a once-daily leukotriene receptor antagonist in the treatment of chronic asthma. A multicenter, randomized, double-bling trial. Arch Intern Med 1998;158:1213-20.
3. Kemp JP, Dockborn RJ, Shapiro GG, Nguyen H, Reiss TF, Seidenberg BC et al. Montelukast once daily inhibits exercise-induce bronchoconstriction in 6-to 14-year-old children with asthma. J Pediatr 1998;133:424-8.
4. Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L et al. Montelukast, a lekotriene-receptor antagonist, for the treatment of mild asthma and exercise-indiced bronchoconstriction. N Engl J Med 1998;339:147-52.
5. Lehnigk B, Rabe KF, Dent G, Herts RS, Carpentier PJ MH. Effects of a 5-lipoxygenase inhibit, ABT-761 on exercise-induced bronchoconstriction and urinary LTE4 in asthmatic patients. Eur Respir J 1998;11:617-23.
6. Spector S. Leukotriene activity modulation in asthma. Drugs 1997;54:369-84.
7. WJ C. Summary of clinical trials with zafirlukast. Am J Respirat Crit Care Med 1998;157(6 pt 2):s238-s245.
8. Knorr B, Noonan G, McBurney J, Zhang J, Nguyen H, Shingo S et al. Evaluation of the safety profile of montelukast (MK-0476) in adult and pediatric patients (aged 6 to 14 years). Eur Respir J 1997;10supl 25:2808.
9. Malmstrom K, Rodríguez-Gómez G, Guerra J, Villaran C, Piñeiro A, Wei LX et al. Oral montelukast, inhales beclomethasone and placebo for chronic asthma. Ann Intern Med 1999;130:487-95.
10. Noonan G, Reiss RG, Shingo S, Nguyan HH, Knorr B, Groups atMAaPS. Montelukast (MK-0476) maintains long term asthma control in adults and pediatric patients (aged ≥ 6 years). Am J Respir Crit Care Med 1999;159:A640.
11. Villaran C, Shane JO, Helbling A, Van Noord JA, Lee TH, Chuchalin AG et al. Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. J Allergy Clin Immunol 1999;104:547-53.
12. Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC, Peszek I et al. Montelukast added to inhaled beclomethasone in treatment of asthma. Am J Respir Crit Care Med 1999;160:1862-8.
13. Löfdahl CG, Reiss TF, Leff JA, Israel E, Noonan J, Finn AF et al. Randmosed, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast on tapering inhaled corticosteriods in asthmatic patients. BMJ 1999; 319:87-90.
14. Diamant Z, Grootendorst DC, Veselic-Charvat M, Timmers MC, De Smet M, Leff JA et al. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma. Clin Exp Allergy 1999;20:42-51.
15. Pizzichini E, Leff JA, Reiss TF, Hendeles L, Boulet LP, Wei LX et al. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir 1999;14:12-8.
16. Braton DL, Lanz MJ, Miyazawa N, White CW, PS. Exhaled nitrix oxide before and after montelukast sodium therapy in school-age children with chronic asthma: a preliminary study. Pediatr Pulmonol 1999;28:402-7.
17. Bisgaard H, Loland L, JA. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonis montelukast. Am J Respir Crit Care Med 1999;160:1227-31.
18. Volovitz B, Tachnick E, Nussinovitch M, Shtaif B, Blau H, Gil-Ad I et al. Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma. J Allergy Clin Immunol 1999;104:1162-7.